Taiwan's Food and Drug Administration (FDA) on Friday issued a product warning for the weight loss drug Belviq, after American medical authorities reported on Thursday that clinical trials on the drug's active ingredient, lorcaserin, showed an increased risk of several types of cancer.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Detention of Ko Wen-je, 3 other defendants ordered to be extended
05/27/2025 11:11 PM - Society
- Culture
Dongyin Township in Matsu Islands joins global Cittaslow network
05/27/2025 09:16 PM - Society
Court rules in Tsai Ing-wen's favor over degree legitimacy case
05/27/2025 09:09 PM - Society
NT$200 million in assets seized from dark web drug suspect detained in U.S.
05/27/2025 08:59 PM